OTC Markets Group Welcomes Medicrea to OTCQX
"We are pleased to welcome Medicrea to the OTCQX Best Market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group.
NEW YORK, Aug. 28, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Medicrea (Euronext Paris: ALMED; OTCQX: MRNTY, MRNTF), a company pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ technologies, has qualified to trade on the OTCQX® Best Market.
Medicrea begins trading today on OTCQX under the symbols "MRNTY" and "MRNTF". U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are pleased to welcome Medicrea to the OTCQX Best Market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "International companies on the OTCQX Market, on average, have increased U.S. ownership and improved trading volume in their home market, according to a recent study conducted by Oxford Metrica. Trading on the OTCQX Market will enable Medicrea to expand its shareholder base and visibility in the U.S."
"We are delighted to join the OTCQX Market. The establishment of an American Depositary Receipts (ADRs) program and our ordinary share in the US will provide our growing US investor base with simple and efficient access to our securities. Joining OTCQX will complement our European presence on EURONEXT Growth – Paris, providing additional liquidity trading to our global shareholders community," commented Denys Sournac, Chief Executive Officer of Medicrea.
Medicrea was sponsored for OTCQX by MCAP LLC, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
About Medicrea (www.medicrea.com)
Through the lens of predictive medicine, Medicrea leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 200 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS and OTC Link ECN are operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, [email protected]
View original content with multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-medicrea-to-otcqx-300702882.html
SOURCE OTC Markets Group Inc.
